Reference
Medicines and Healthcare products Regulatory Agency (UK). Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results. Drug Safety Update 11: 5-6, No. 12, Jul 2018. Available from: URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/726260/DSU-July-PDF.pdf
Rights and permissions
About this article
Cite this article
Laboratory test interference associated with eltrombopag. Reactions Weekly 1712, 2 (2018). https://doi.org/10.1007/s40278-018-49291-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-49291-2